FTC and seven states ask court to hold Martin Shkreli in contempt for violating pharmaceutical industry ban
The Federal Trade Commission and attorneys general from seven states filed a court motion on October 13, 2026, asking a federal judge to hold Martin Shkreli in contempt for allegedly violating a lifetime ban from the pharmaceutical industry. Authorities allege Shkreli publicly livestreamed pharmaceutical stock trades and commentary on social media since his 2022 prison release. They are seeking disgorgement of profits, fines, and potential imprisonment.
18
Divergence score
5 outlets covered it, splitting into 5 framing camps across 3 bias groups.
5 camps
3 bias groups
The spectrum · how 5 outlets placed this story
LeftCenterRight
CNN
Washington Times
Financial Times
The Hill
NY Post
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
Furthest apart on this story
CNN
'Pharma Bro' Martin Shkreli has caught the attention of federal and state authorities again
investigative detail-heavy narrative · negative
Washington Times
'Pharma Bro' Martin Shkreli accused of violating court order by dealing in pharmaceuticals again
includes Shkreli's political pushback · neutral
First to report
- CNNfirst
- Financial Times+5.2 h
- The Hill+6.3 h
- Washington Times+6.9 h
- NY Post+11.6 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
Coverage aligns on core facts; the Washington Times adds Shkreli's own voice calling the Trump FTC's involvement "very surprising", while CNN highlights the "tip of the iceberg" warning and his sister's alleged involvement, details others omit or downplay.
How each outlet covered it
Broad agreement on what happened
Outlets across the spectrum land in roughly the same place: the shared language is highlighted.
THE LEFT
“'Pharma Bro' Martin Shkreli has caught the attention of federal and state authorities again”CNN CNN LEFT
18LOW DIVERGENCE
THE RIGHT
“'Pharma Bro' Martin Shkreli accused of violating court order by dealing in pharmaceuticals again”WT Washington Times RIGHT
DOWN THE MIDDLE
“FTC: 'Pharma bro' Shkreli violated lifetime industry ban, should be held in contempt” · The Hill
+Hide the full sourcingSee how all 5 outlets put it
7 tracked claims across 5 outlets
Fact ledger
All7Claimed3Corroborated4
1/5
Claimed
Shkreli's sister and her partner appear to have assisted him in the alleged violations
Corroborated
Disputed
6 more tracked claimsSign up free to see the full ledger